Advertisement
Organisation › Details
Flagship Ventures Fund V
Realizing entrepreneurial innovation is the mission of Flagship Ventures. Founded in 2000, the firm has launched 30 companies while investing in another 50. Flagship manages $1.4 billion in capital and is active in three principal sectors: therapeutics, health technologies, and sustainability. Flagship’s current portfolio includes Acceleron (NASDAQ: XLRN), Agios (NASDAQ: AGIO), BIND Therapeutics (NASDAQ: BIND), Concert Pharmaceuticals (NASDAQ: CNCE), Eleven Biotherapeutics (NASDAQ: EBIO), T2 Biosystems (NASDAQ: TTOO), Tetraphase (NASDAQ: TTPH) as well as several private companies: Editas Medicine, Pronutria Biosciences, Seres Health and Moderna Therapeutics. *
Start | 2015-03-01 closing | |
Group | Flagship Pioneering | |
Industry | venture capital | |
Industry 2 | HEALTH (HUMAN) | |
Region | Cambridge, MA | |
Country | United States (USA) | |
Street | 1 Memorial Drive 7th Floor | |
City | 02142 Cambridge, MA | |
Tel | +1-617-868-1888 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
Currency | USD | |
Annual sales | 537,000,000 (capital under management 2015-03-01) | |
* Document for »About Section«: | ||
Record changed: 2021-05-24 |
Advertisement
More documents for Flagship Pioneering
- [1] Seagen Inc.. (11/10/22). "Press Release: Seagen Names David R. Epstein as Chief Executive Officer and Director". Bothell, WA....
- [2] Repertoire Immune Medicines. (4/13/21). "Press Release: Repertoire Immune Medicines Secures $189M Financing to Advance Pipeline Programs and Discovery Platform Directed at Cellular Immune Targets". Cambridge, MA....
- [3] Flagship Pioneering. (11/16/20). "Press Release: Flagship Pioneering Announces Appointment of Dr. Luciano Rossetti as New Chief Medical Officer". Cambridge, MA....
- [4] Flagship Pioneering. (11/12/19). "Press Release: Flagship Pioneering Appoints Prakash Raman, Ph.D. as Senior Partner and Chief Business Development Officer". Cambridge, MA....
- [5] Lipotype GmbH. (9/13/17). "Press Release: Lipid Analysis for Early Stages of Drug Discovery – Customer Reference Flagship VentureLabs"....
- [6] Rubius Therapeutics, Inc.. (1/4/17). "Press Release: Rubius Therapeutics Announces Appointment of Top Leadership. Company Taps Industry Leaders Epstein and Straight Nissen to Advance Potential Life Saving Technology Platform". Cambridge, MA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top